Mass spectrometry‐based targeted proteomics for analysis of protein mutations
Authors:
- 31 October 2021
- journal article
- review article
- Published by Wiley in Mass Spectrometry Reviews
- Vol. 42 (2) , 796-821
Abstract
Cancers are caused by accumulated DNA mutations. This recognition of the central role of mutations in cancer and recent advances in next‐generation sequencing, has initiated the massive screening of clinical samples and the identification of 1000s of cancer‐associated gene mutations. However, proteomic analysis of the expressed mutation products lags far behind genomic (transcriptomic) analysis. With comprehensive global proteomics analysis, only a small percentage of single nucleotide variants detected by DNA and RNA sequencing have been observed as single amino acid variants due to current technical limitations. Proteomic analysis of mutations is important with the potential to advance cancer biomarker development and the discovery of new therapeutic targets for more effective disease treatment. Targeted proteomics using selected reaction monitoring (also known as multiple reaction monitoring) and parallel reaction monitoring, has emerged as a powerful tool with significant advantages over global proteomics for analysis of protein mutations in terms of detection sensitivity, quantitation accuracy and overall practicality (e.g., reliable identification and the scale of quantification). Herein we review recent advances in the targeted proteomics technology for enhancing detection sensitivity and multiplexing capability and highlight its broad biomedical applications for analysis of protein mutations in human bodily fluids, tissues, and cell lines. Furthermore, we review recent applications of top‐down proteomics for analysis of protein mutations. Unlike the commonly used bottom‐up proteomics which requires digestion of proteins into peptides, top‐down proteomics directly analyzes intact proteins for more precise characterization of mutation isoforms. Finally, general perspectives on the potential of achieving both high sensitivity and high sample throughput for large‐scale targeted detection and quantification of important protein mutations are discussed.Keywords
This publication has 163 references indexed in Scilit:
- Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay testsJournal of Proteomics, 2012
- Advancing the sensitivity of selected reaction monitoring‐based targeted quantitative proteomicsProteomics, 2012
- Peptide Immunoaffinity Enrichment Coupled with Mass Spectrometry for Peptide and Protein QuantificationClinics In Laboratory Medicine, 2011
- Improving Liquid Chromatography-Mass Spectrometry Sensitivity Using a Subambient Pressure Ionization with Nanoelectrospray (SPIN) InterfaceJournal of the American Society for Mass Spectrometry, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Simultaneous Analysis of Glycosylated and Sialylated Prostate-Specific Antigen Revealing Differential Distribution of Glycosylated Prostate-Specific Antigen Isoforms in Prostate Cancer TissuesAnalytical Chemistry, 2010
- Achieving 50% Ionization Efficiency in Subambient Pressure Ionization with NanoelectrosprayAnalytical Chemistry, 2010
- Selected reaction monitoring for quantitative proteomics: a tutorialMolecular Systems Biology, 2008
- Subambient Pressure Ionization with Nanoelectrospray Source and Interface for Improved Sensitivity in Mass SpectrometryAnalytical Chemistry, 2008
- The Hallmarks of CancerCell, 2000